Skip to Content

Progesterone Injection

Last Updated: April 5, 2018
Status: Current

Progesterone Injection

Products Affected - Description
    • Progesterone intramuscular injection, American Regent, 50 mg/mL, 10 mL vial, 1 count, NDC 00517-0750-01
    • Progesterone intramuscular injection, Fresenius Kabi, 50 mg/mL, 10 mL vial, 1 count, NDC 63323-0261-10
    • Progesterone intramuscular injection, Teva, 50 mg/mL, 10 mL vial, 1 count, NDC 00591-3128-79
    • Progesterone intramuscular injection, West-Ward, 50 mg/mL, 10 mL vial, 1 count, NDC 00143-9725-01
Reason for the Shortage
    • American Regent did not provide a reason for the shortage.
    • Fresenius Kabi has progesterone on shortage due to increased demand and manufacturing delays.
    • Teva has progesterone on shortage due to supply constraints.
    • West-Ward has progesterone on shortage due to manufacturing delays.

Estimated Resupply Dates

    • American Regent has progesterone in oil 50 mg/mL 10 mL vials for intramuscular injection on back order and the company cannot estimate a release date.
    • Fresenius Kabi has progesterone in oil 50 mg/mL 10 mL vials for intramuscular injection on back order and the company estimates a release date of 2nd quarter 2018. Check wholesaler for availability.
    • Teva has progesterone in oil 50 mg/mL 10 mL vials for intramuscular injection on back order and the company estimates a release date of late-April 2018.
    • West-Ward has progesterone in oil 50 mg/mL 10 mL vials for intramuscular injection on allocation.

Updated

Updated April 5, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 24, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide